Daniel SontupeMarket Access
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
TYME’s novel metabolic-based investigational cancer therapy, SM-88, demonstrated encouraging results and a well-tolerated safety ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email